Omega Diagnostics CEO (LON:ODX) Colin King introduces the business to Proactive London's Andrew Scott and its main areas of focus - CD4, infectious diseases and food intolerance testing. He says while some areas of the business have been slowed by the pandemic they're rapidly developing new tests for COVID-19 that will need to be made and sold in significant volume.
16 Jul 20